| DIRECT COMPETITOR COMPARISON | |
| ACHN | GSK | JNJ | RHHBY.PK | Industry | | Market Cap: | 50.11M | 108.45B | 174.62B | N/A | 97.43M | | Employees: | 40 | 99,003 | 118,700 | N/A | 65 | | Qtrly Rev Growth (yoy): | N/A | 14.90% | -5.30% | N/A | 19.70% | | Revenue (ttm): | -1.64M | 45.19B | 60.53B | N/A | 14.05M | | Gross Margin (ttm): | N/A | 76.27% | 71.08% | N/A | 63.92% | | EBITDA (ttm): | -26.46M | 17.81B | 19.05B | N/A | -12.30M | | Oper Margins (ttm): | 1,663.94% | 34.30% | 26.94% | N/A | -124.89% | | Net Income (ttm): | -27.91M | 8.12B | 12.77B | N/A | N/A | | EPS (ttm): | -1.053 | 3.18 | 4.579 | N/A | -0.32 | | P/E (ttm): | N/A | 13.45 | 13.82 | N/A | 16.41 | | PEG (5 yr expected): | N/A | 3.01 | 1.86 | 1.37 | 1.31 | | P/S (ttm): | N/A | 2.37 | 2.88 | N/A | 9.54 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.27 | 0.83% | 57.97B | 12.49 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.41 | 0.06% | 13.71B | 15.87 | | Genzyme Corp. | GENZ | 51.34 | 1.91% | 13.62B | 29.27 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.94 | -0.04% | 42.24B | 18.15 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.81 | 1.26% | 9.06B | 1036.94 | | Teva Pharmaceutical Industries Limited | TEVA | 53.25 | -0.04% | 46.91B | 48.72 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.72 | 1.81% | 4.00B | 19.44 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.09 | 0.08% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.31 | 0.05% | 5.60B | 112.33 | | Pfizer Inc. | PFE | 18.44 | 0.71% | 148.80B | 15.32 | | Johnson & Johnson | JNJ | 63.29 | 0.17% | 174.62B | 13.82 | | GlaxoSmithKline plc | GSK | 42.7803 | 1.18% | 108.45B | 13.45 | | Sanofi-Aventis | SNY | 39.35 | 1.86% | 102.75B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.71 | 0.74% | 126.53B | 16.68 | | RHHBY.PK | 42.04 | 1.42% | N/A | N/A | | AstraZeneca plc | AZN | 46.37 | 2.48% | 67.24B | 9.31 | | Abbott Laboratories | ABT | 54.39 | 0.28% | 84.13B | 14.74 | | Bristol-Myers Squibb Co. | BMY | 25.53 | 1.47% | 50.57B | 13.21 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|